Invest Daily Pro
  • Economy
  • Investing
No Result
View All Result
  • Economy
  • Investing
No Result
View All Result
Invest Daily Pro
No Result
View All Result
Home Economy

New Alzheimer’s Blood Test Now Accessible in the UK

by
November 18, 2024
in Economy, Investing
0
New Alzheimer’s Blood Test Now Accessible in the UK
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Advance Tests, a leader in advanced diagnostics, has announced the launch of LucentAD Complete in the United Kingdom, a new and innovative blood test for the early detection of Alzheimer’s Disease. Developed by Lucent Diagnostics, a commercial brand of Quanterix Corporation, this groundbreaking test combines multiple biomarkers to accurately classify the risk of amyloid pathology associated with Alzheimer’s Disease.

The partnership between Lucent Diagnostics and Advance Tests allows for the test to be available to patients and healthcare providers in the UK, with appointments starting on December 2nd. This launch marks a significant milestone in providing accessible and accurate Alzheimer’s diagnostics in the UK.

The LucentAD Complete test offers several advantages, including its availability for bookings starting now and its high accuracy of 90% in detecting amyloid pathology. Priced at £695, the test is a cost-effective alternative to PET imaging and lumbar punctures, which can be significantly more expensive. It also requires only a blood sample, making it non-invasive and eliminating the need for costly imaging procedures. This aligns with Advance Tests’ mission to make life-saving diagnostics widely accessible.

The test utilizes multiple biomarkers, including p-Tau 217, to improve amyloid detection and provide conclusive results for approximately 90% of cases. It meets the performance standards set by the Global CEO Initiative on Alzheimer’s Disease and the US Alzheimer’s Association, offering a more advanced option compared to current gold standard diagnostic approaches.

The test will be available on a private basis, with appointments offered at Advance Tests’ first clinic on St Thomas Street in London. Additional clinics are planned for cities across the UK to expand patient access to this transformative diagnostic tool. Appointments can be booked directly or through healthcare providers via www.advancetests.com.

Dr. Simon Worrell, Founder and Chief Medical Officer of Advance Tests, expressed his pride in bringing LucentAD Complete to the UK and the potential it has to transform Alzheimer’s care. He also mentioned working with Quanterix to remove barriers to early diagnosis and provide timely treatment that can greatly impact patients’ lives.

Dr. Karan Jutlla, Head of the Centre for Applied and Inclusive Health Research at the University of Wolverhampton, also commented on the introduction of LucentAD Complete, stating that having access to this sophisticated, non-invasive blood test is a game-changer for early Alzheimer’s diagnosis in the UK. This test simplifies diagnostics, making it easier for more patients to access critical care, especially with new therapies for early-stage Alzheimer’s becoming available.

Advance Tests collaborates with globally trusted biotech innovators to introduce their breakthrough diagnostic technologies to the UK market. Their team brings unparalleled expertise in the commercialization of cutting-edge technology and is committed to pioneering accessible diagnostic solutions worldwide. For more information, visit www.advancetests.com.

Media Contact: Stephen Simpson, Advance Tests

stephen.simpson@advancetests.com

07792767529

Distributed by https://pressat.co.uk/

ShareTweetPin

Related Posts

10 Biggest Cannabis Stocks in the US and Canada
Investing

10 Biggest Cannabis Stocks in the US and Canada

July 23, 2025
10 Biggest Cannabis Stocks in the US and Canada
Investing

10 Biggest Cannabis Stocks in the US and Canada

July 23, 2025
Altech Batteries LtdCerenergy Battery Project Funding Progressing Well
Investing

Altech Batteries LtdCerenergy Battery Project Funding Progressing Well

July 23, 2025
Altech Batteries LtdCerenergy Battery Project Funding Progressing Well
Investing

Altech Batteries LtdCerenergy Battery Project Funding Progressing Well

July 23, 2025
Lithium Market Update: Q2 2025 in Review
Investing

Lithium Market Update: Q2 2025 in Review

July 22, 2025
John Feneck: Gold, Silver, Platinum, Copper — 8 Stocks to Play These Metals
Investing

John Feneck: Gold, Silver, Platinum, Copper — 8 Stocks to Play These Metals

July 22, 2025
Next Post
Fleet Safety Systems Celebrates 25 Years of Expertise in Fleet Safety

Fleet Safety Systems Celebrates 25 Years of Expertise in Fleet Safety

Recommended

CTA denies Pilipinas Shell’s P43-million tax refund claim

CTA denies Pilipinas Shell’s P43-million tax refund claim

October 31, 2024
Reinsurance seen shielding gov’t from PhilHealth cost blowouts

Reinsurance seen shielding gov’t from PhilHealth cost blowouts

December 25, 2024

Basilan peace ties strengthened

September 22, 2024
How To Choose the Best Online Casino Payment Methods

How To Choose the Best Online Casino Payment Methods

October 2, 2024
“Knus Chosen for Prestigious Hatch City Bridge Foundation Accelerator Program”

“Knus Chosen for Prestigious Hatch City Bridge Foundation Accelerator Program”

September 20, 2024
How Connect Me Better Helps Forward-Thinking Small Businesses Succeed

How Connect Me Better Helps Forward-Thinking Small Businesses Succeed

October 28, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 InvestDailyPro. All Rights Reserved.

    Disclaimer: InvestDailyPro.com, its managers, its employees, and assigns (collectively InvestDailyPro ) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    No Result
    View All Result
    • About us
    • Contact us
    • Home
    • Privacy Policy
    • Suspicious engagement
    • Terms & Conditions
    • Thank you

    Copyright © 2025 investdailypro.com | All Rights Reserved